Acetate supplementation reduces microglia activation and brain interleukin-1β levels in a rat model of Lyme neuroborreliosis

Journal of Neuroinflammation

Volumn 9, Issue 1, 2012, Pages

  Brissette, Catherine A ^a   Houdek, Heidi M ^a   Floden, Angela M ^a   Rosenberger, Thad A ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Acetate; Astrocytes; Microglia; Neuroborreliosis; Neuroinflammation

Indexed keywords

INTERLEUKIN 1BETA; TRIACETIN; ABIETANE DERIVATIVE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CD11B ANTIGEN; CYTOKINE; DNA BINDING PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCERYL TRIABIETATE; RECA PROTEIN; RECA PROTEIN, ACINETOBACTER CALCOACETICUS; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BACTERIAL VIRULENCE; BORRELIA BURGDORFERI; BRAIN LEVEL; BRAIN NERVE CELL; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; LYME NEUROBORRELIOSIS; MALE; MICROGLIA; NONHUMAN; RAT; ANALYSIS OF VARIANCE; ANIMAL; BRAIN; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYME DISEASE; METABOLISM; MICROBIOLOGY; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; ANTIGENS, CD11B; BACTERIAL PROTEINS; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; DITERPENES, ABIETANE; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN-1BETA; LYME NEUROBORRELIOSIS; MALE; MICROGLIA; RATS; RATS, SPRAGUE-DAWLEY; REC A RECOMBINASES; TRIGLYCERIDES;

EID: 84868307408     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-249     Document Type: Article

References (44)

1. Lyme Disease Data: http://www.cdc.gov/lyme/stats/index.html
2. Barthold SW, de Souza MS, Janotka JL, Smith AL, Persing DH: Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol 1993, 143:959-972
3. Stanek G, Strle F: Lyme borreliosis. Lancet 2003, 362:1639-1647
4. Steere AC: Lyme disease. New Engl J Med 2001, 345:115-125
5. Rupprecht TA, Koedel U, Fingerle V, Pfister HW: The pathogenesis of lyme neuroborreliosis: from infection to inflammation. Mol Med 2008, 14:205-212
6. Fallon BA, Levin ES, Schweitzer PJ, Hardesty D: Inflammation and central nervous system Lyme disease. Neurobiol Dis 2010, 37:534-541
7. Hildenbrand P, Craven DE, Jones R, Nemeskal P: Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis. Am J Neuroradiol 2009, 30:1079-1087
8. Bernardino AL, Myers TA, Alvarez X, Hasegawa A, Philipp MT: Toll-like receptors: insights into their possible role in the pathogenesis of lyme neuroborreliosis. Infect Immun 2008, 76:4385-4395
9. Ramesh G, Borda JT, Dufour J, Kaushal D, Ramamoorthy R, Lackner AA, Philipp MT: Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis. Am J Pathol 2008, 173:1415-1427
10. Namboodiri AM, Peethambaran A, Mathew R, Sambhu PA, Hershfield J, Moffett JR, Madhavarao CN: Canavan disease and the role of Nacetylaspartate in myelin synthesis. Mol Cell Endocrinol 2006, 252:216-223
11. Reisenauer CJ, Bhatt DP, Mitteness DJ, Slanczka ER, Gienger HM, Watt JA, Rosenberger TA: Acetate supplementation attenuates lipopolysaccharideinduced neuroinflammation. J Neurochem 2011, 117:264-274
12. Ariyannur PS, Moffett JR, Madhavarao CN, Arun P, Vishnu N, Jacobowitz DM, Hallows WC, Denu JM, Namboodiri AM: Nuclear-cytoplasmic localization of acetyl coenzyme a synthetase-1 in the rat brain. J Comp Neurol 2010, 518:2952-2977
13. Fujino T, Kondo J, Ishikawa M, Morikawa K, Yamamoto TT: Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate. J Biol Chem 2001, 276:11420-11426
14. Soliman ML, Rosenberger TA: Acetate supplementation increases brain histone acetylation and inhibits histone deacetylase activity and expression. Mol Cell Biochem 2011, 352:173-180
15. Soliman ML, Smith MD, Houdek HM, Rosenberger TA: Acetate supplementation modulates brain histone acetylation and decreases interleukin-1beta expression in a rat model of neuroinflammation. J Neuroinflammation 2012, 9:51
16. Soliman ML, Puig KL, Combs CK, Rosenberger TA: Acetate reduces microglia inflammatory signaling in vitro. J Neurochem 2012, 123:555-567
17. Deutsch J, Rapoport SI, Rosenberger TA: Coenzyme A and short-chain acyl-CoA species in control and ischemic rat brain. Neurochem Res 2002, 27:1577-1582
18. Gorisch SM, Wachsmuth M, Toth KF, Lichter P, Rippe K: Histone acetylation increases chromatin accessibility. J Cell Science 2005, 118:5825-5834
19. Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM: Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 2007, 321:892-901
20. Rouaux C, Panteleeva I, Rene F, de Aguilar JL G, Echaniz-Laguna A, Dupuis L, Menger Y, Boutillier AL, Loeffler JP: Sodium valproate exerts neuroprotective effects in vivo through CREB-binding proteindependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J Neurosci 2007, 27:5535-5545
21. Zhang B, West EJ, Van KC, GurkoffGG, Zhou J, Zhang XM, Kozikowski AP, Lyeth BG: HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats. Brain Res 2008, 1226:181-191
22. Saha RN, Pahan K: HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 2006, 13:539-550
23. Casjens S, Palmer N, van Vugt R, Huang WM, Stevenson B, Rosa P, Lathigra R, Sutton G, Peterson J, Dodson RJ, Haft D, Hickey E, Gwinn M, White O, Fraser CM: A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs of an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 2000, 35:490-516
24. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, White O, Ketchum KA, Dodson R, Hickey EK, Gwinn M, Dougherty B, Tomb JF, Fleischmann RD, Richardson D, Peterson J, Kerlavage AR, Quackenbush J, Salzberg S, Hanson M, van Vugt R, Palmer N, Adams MD, Gocayne J, Weidman J, Utterback T, Watthey L, McDonald L, Artiach P, Bowman C, et al: Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997, 390:580-586
25. Zückert WR: Laboratory maintenance of Borrelia burgdorferi. In Current Protocols In Microbiology. Edited by Coico RT, Kowalik TF, Quarles J, Stevenson B, Taylor R. Hoboken, NJ: J. Wiley and Sons; 2007:12C.11.11-12C.11.10
26. Morrison TB, Ma Y, Weis JH, Weis JJ: Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J Clin Microbiol 1999, 37:987-992
27. Rosengren S, Firestein GS, Boyle DL: Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 2003, 10:1002-1010
28. Hulse RE, Kunkler PE, Fedynyshyn JP, Kraig RP: Optimization of multiplexed bead-based cytokine immunoassays for rat serum and brain tissue. J Neurosci Methods 2004, 136:87-98
29. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254
30. Shi SR, Key ME, Kalra KL: Antigen retrieval in formalin-fixed, paraffinembedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991, 39:741-748
31. Ramesh G, Borda JT, Gill A, Ribka EP, Morici LA, Mottram P, Martin DS, Jacobs MB, Didier PJ, Philipp MT: Possible role of glial cells in the onset and progression of Lyme neuroborreliosis. J Neuroinflammation 2009, 6:23
32. Myers TA, Kaushal D, Philipp MT: Microglia are mediators of Borrelia burgdorferi-induced apoptosis in SH-SY5Y neuronal cells. PLoS Pathog 2009, 5:e1000659
33. Zhao H, Xiao S, Kong X, Wang J, Cao X, Gencheng W, Loh HH, Law PY: Neuron-glial cell communication in the traumatic stress-induced immunomodulation. Synapse 2011, 65:433-440
34. Gehrmann J, Bonnekoh P, Miyazawa T, Hossmann KA, Kreutzberg GW: Immunocytochemical study of an early microglial activation in ischemia. J Cereb Blood Flow Metab 1992, 12:257-269
35. van Dam AM, Brouns M, Louisse S, Berkenbosch F: Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? Brain Res 1992, 588:291-296
36. Mayne M, Fotheringham J, Yan HJ, Power C, Del Bigio MR, Peeling J, Geiger JD: Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage. Ann Neurol 2001, 49:727-735
37. Guzman M, Blazquez C: Ketone body synthesis in the brain: possible neuroprotective effects. Prostaglandins Leukot Essent Fatty Acids 2004, 70:287-292
38. Cullingford TE: The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders. Prostaglandins Leukot Essent Fatty Acids 2004, 70:253-264
39. Di Filippo M, Chiasserini D, Tozzi A, Picconi B, Calabresi P: Mitochondria and the link between neuroinflammation and neurodegeneration. J Alzheimers Dis 2010, Suppl 2:S369-S379
40. Block ML, Zecca L, Hong JS: Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Rev Neurosci 2007, 8:57-69
41. Tyagi E, Agrawal R, Nath C, Shukla R: Influence of LPS-induced neuroinflammation on acetylcholinesterase activity in rat brain. J Neuroimmunol 2008, 205:51-56
42. O'Shea JJ, Ma A, Lipsky P: Cytokines and autoimmunity. Nature Rev Immunol 2002, 2:37-45
43. Ferger AI, Campanelli L, Reimer V, Muth KN, Merdian I, Ludolph AC, Witting A: Effects of mitochondrial dysfunction on the immunological properties of microglia. J Neuroinflammation 2010, 7:45
44. Beal MF: Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 2005, 58:495-505